4.1 Antiretroviral therapies for HIV

Medical Journal of Australia

Volumn 164, Issue 5, 1996, Pages 290-295

  Crowe, Suzanne ^a   Cooper, David A ^b,c   Chambers, Diane E ^d  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Leichhardt Family Medical Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; ZALCITABINE; ZIDOVUDINE; ACICLOVIR; CD4 ANTIGEN; DAPSONE; DELAVIRDINE; GANCICLOVIR; INTEGRASE; KETOCONAZOLE; LAMIVUDINE; LOVIRIDE; NEVIRAPINE; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

CLINICAL TRIAL; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTICENTER STUDY; REVIEW; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; BLOOD TOXICITY; ELECTROLYTE DISTURBANCE; FATTY LIVER; HEPATITIS; HUMAN CELL; LACTIC ACIDOSIS; LYMPHOCYTE COUNT; META ANALYSIS; MOOD; MOUTH ULCER; MYOPATHY; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREATITIS; PERIPHERAL NEUROPATHY; PIGMENT DISORDER; RASH; RETROVIRUS INFECTION; RHABDOMYOLYSIS; THROMBOCYTOPENIA; VIRUS REPLICATION; XEROSTOMIA;

ANTIVIRAL AGENTS; CLINICAL TRIALS; DIDANOSINE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MULTICENTER STUDIES; ZALCITABINE; ZIDOVUDINE;

EID: 0029914843     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb94194.x     Document Type: Article

References (20)

1. Wain-Hobson S Virologic mayhem Nature 1995, 373 102
2. Ho DD, Neumann AU Perelson A, et al Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 1995, 373 123-126
3. Wei X, Ghosh SK, Taylor ME, et al Viral dynamics in HIV-1 infection Nature 1995, 373 117-122
4. Land S, McGavin C, Lucas R, et al Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before during, and after therapy J Infect Dis 1992. 166 1139-1142
5. Mulder JW, Cooper DA, Mathiesen L, et al Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS a randomised, double-blind placebo-controlled study AIDS 1994, 8 313-321
6. D'Aquila RT Johnson VA, Welles SL, et al Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy Ann Intern Med 1995, 122 401-408
7. Fischl MA, Richman DD, Grieco MH, et al The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex, a double-blind, placebo-controlled trial N Engl J Med 1987, 317 185-191
8. Volberding PA, Lagakos SW, Koch MA, et al Zidovudine in asymptomatic human immunodeficiency virus infection, a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter N Engl J Med 1990, 322 941-949
9. Cooper DA Gatell JM, Kroon S, et al Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter N Engl J Med 1993, 329 297-303
10. Concorde Co-ordinating Committee Concorde MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection Lancet 1994, 343 871-881
11. Connor EM, Sperling RS Gelber R, et al Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 1994, 331 1173-1180
12. Abrams DI Goldman AI, Launer C, et al A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection N Engl J Med 1994, 330 657-662
13. Kahn JO, Lagakos SW, Richman DD, et al. Controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection (ACTG 116B/117) N Engl J Med 1992, 327 581-587
14. Kinloch-Loes S, Hirshel BJ, Hoen B, et al A controlled trial of zidovudine in primary HIV infection N Engl J Med 1995, 333. 408-413
15. Collier AC, Coombs RW, Fishl MA, et al Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection Ann Intern Med 1993, 119 786-793
16. Cooper DA, Pehrson PO, Pedersen C, et al The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex, a double-blind randomized trial AIDS 1993; 7 197-207
17. Hamilton JD, Hartigan PW, Simberkoff MS, et al A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection, results of the Veterans Affairs Co-operative Study N Engl J Med 1992; 326 437-443
18. Fischl MA, Richman DD, Hansen N, et al The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic HIV infection a double blind, placebo controlled trial Ann Intern Med 1990, 112 727-737
19. Fischl MA Stanley K, Collier A, et al Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. Ann Intern Med 1995, 122 24-32
20. Stein DS, Graham NMH, Park LP, et al The effect of the interaction of acyclovir with zidovudine on progression in AIDS and survival, analysis of data in the Multicentre AIDS Cohort Study Ann Intern Med 1994, 121 100-108